Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Sunway Medical Centre Velocity Awarded by Frost & Sullivan for Leading the Malaysian Hospital Industry with Holistic Medical Care and Pioneering Technologies
2023-06-02 11:46
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China
2023-06-02 08:00
CAMH study confirms ongoing brain inflammation associated with long COVID
2023-06-02 04:07
EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally
2023-06-02 00:10
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
2023-06-02 00:06
AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout
2023-06-01 21:00
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA
2023-06-01 20:30
Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
2023-06-01 17:18
CRScube Expands Services in Europe with New Clinical Study Collaborations
2023-06-01 16:00
New Genea Fertility Clinic to Open in North Melbourne
2023-06-01 15:58
GenesisCare Files for Voluntary Reorganisation to Advance Business Transformation
2023-06-01 14:09
Antengene Announces XPOVIO® plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma
2023-06-01 10:09
National Comprehensive Cancer Network Joins Collaboration to Improve Standards in Cancer Care for Vietnam
2023-06-01 09:00
Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy
2023-06-01 09:00
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders
2023-06-01 08:00
Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument
2023-06-01 00:57
Advances of Qilu Pharmaceutical's QL1706 in Clinical Research Presented at ASCO Annual Meeting
2023-06-01 00:55
Vazyme Signs Global Strategic Cooperation Agreement with Azenta
2023-05-31 22:24
Caliway Biopharmaceuticals Announces Initiation of Subject Recruitment in CBL-0204 Phase 2b Study Evaluating the Efficacy of CBL-514 in Abdominal Subcutaneous Fat Reduction
2023-05-31 20:15
THINK Surgical's TMINI Miniature Robotic System developed with Sagentia Innovation gains FDA 510(k) clearance
2023-05-31 15:00
1
106
107
108
109
110
532